Matches in Wikidata for { <http://www.wikidata.org/entity/Q96155542> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q96155542 description "article scientifique publié en 2020" @default.
- Q96155542 description "artykuł naukowy opublikowany 15 maja 2020" @default.
- Q96155542 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q96155542 description "scientific article published on 15 May 2020" @default.
- Q96155542 description "wetenschappelijk artikel" @default.
- Q96155542 description "наукова стаття, опублікована 15 травня 2020" @default.
- Q96155542 name "Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients" @default.
- Q96155542 name "Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients" @default.
- Q96155542 type Item @default.
- Q96155542 label "Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients" @default.
- Q96155542 label "Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients" @default.
- Q96155542 prefLabel "Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients" @default.
- Q96155542 prefLabel "Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients" @default.
- Q96155542 P1433 Q96155542-A79E66D6-8524-4C61-BA5F-6B0AB543C5E4 @default.
- Q96155542 P1476 Q96155542-239FD3B7-E89C-42D5-B435-D5B0E290DFF1 @default.
- Q96155542 P2093 Q96155542-22716C9A-4BA9-4269-AF3B-A3D9101F5493 @default.
- Q96155542 P2093 Q96155542-468D0BFD-0919-4E3D-AA61-9706CE350BF0 @default.
- Q96155542 P2093 Q96155542-4D759CD0-8917-4623-8F95-FD846515111D @default.
- Q96155542 P2093 Q96155542-799873D5-57F3-431E-AC42-9EDB3CEE1DAD @default.
- Q96155542 P2093 Q96155542-B30BEB61-4D86-407A-B0A6-E2F5039D7C73 @default.
- Q96155542 P2093 Q96155542-BB247B64-D150-44C9-9620-EBFD22278182 @default.
- Q96155542 P2093 Q96155542-CCB846A2-DAB3-4FD7-B1DB-C487AFC5DD48 @default.
- Q96155542 P2093 Q96155542-D52F001A-9EDA-4261-9C94-034D661A17F1 @default.
- Q96155542 P304 Q96155542-1C75D434-A12B-4AE8-9F9B-E20A01563829 @default.
- Q96155542 P31 Q96155542-88926F28-B14E-4CD6-9E84-F353D29063B5 @default.
- Q96155542 P356 Q96155542-DB020D5F-1A29-4F98-AB5F-F67BDE2AD733 @default.
- Q96155542 P478 Q96155542-837618E5-41CA-44A4-85F3-E7FC0F7742A0 @default.
- Q96155542 P50 Q96155542-B0C6C953-90FF-423E-838C-3AC05FD9376E @default.
- Q96155542 P577 Q96155542-875D7103-C95C-47B7-87AF-72D8E41D7DC9 @default.
- Q96155542 P698 Q96155542-943331D2-2D25-44D1-92CD-C1598254BC67 @default.
- Q96155542 P921 Q96155542-10573685-1598-4712-80F7-30DF91367F69 @default.
- Q96155542 P356 J.ATHEROSCLEROSIS.2020.04.024 @default.
- Q96155542 P698 32505012 @default.
- Q96155542 P1433 Q4813570 @default.
- Q96155542 P1476 "Eligibility for PCSK-9 inhibitors treatment in acute coronary syndrome, chronic coronary artery disease and outpatient dyslipidemic patients" @default.
- Q96155542 P2093 "Dimitrios Richter" @default.
- Q96155542 P2093 "Dimitrios Soulis" @default.
- Q96155542 P2093 "Dimitrios Terentes-Printzios" @default.
- Q96155542 P2093 "Dimitrios Tousoulis" @default.
- Q96155542 P2093 "Eirini Solomou" @default.
- Q96155542 P2093 "Ioanna Dima" @default.
- Q96155542 P2093 "Ioannis Skoumas" @default.
- Q96155542 P2093 "Konstantinos Aznaouridis" @default.
- Q96155542 P304 "29-35" @default.
- Q96155542 P31 Q13442814 @default.
- Q96155542 P356 "10.1016/J.ATHEROSCLEROSIS.2020.04.024" @default.
- Q96155542 P478 "303" @default.
- Q96155542 P50 Q88459731 @default.
- Q96155542 P577 "2020-05-15T00:00:00Z" @default.
- Q96155542 P698 "32505012" @default.
- Q96155542 P921 Q266018 @default.